title: Inefficient clearance of dying cells and autoreactivity.
abstract: Dying cells were basically unnoticed by scientists for a long time and only came back into the spotlight roughly 10 years ago. The process of recognition and uptake of apoptotic and necrotic cells is complex and failures in this process can contribute to the pathogenesis of autoimmune diseases such as systemic lupus erythematosus (SLE). Here, we discuss the recognition and uptake molecules which are involved in an efficient clearance of dying cells in early and late phases of cell death. The exposure of phosphatidylserine (PS) is an early surface change of apoptosing cells recognized by several receptors and adaptor molecules. We demonstrated that dying cells have cell membranes with high lateral mobility of PS, which contribute to their efficient clearance. Changes of the glycoprotein composition of apoptotic cells occur later than the exposure of PS. We further observed that complement binding is an early event in necrosis and a rather late event in apoptosis. Complement, C-reactive protein (CRP), and serum DNase I act as back-up molecules in the clearance process. Finally, we discuss how the accumulation of secondary necrotic cells and cellular debris in the germinal centers of secondary lymph organs can lead to autoimmunity. It is reasonable to argue that clearance defects are major players in the development of autoimmune diseases such as SLE.
authors.affiliation: Institute for Clinical Immunology, Friedrich-Alexander-University of Erlangen-Nuremberg, Germany.
authors.forename: U S
authors.initials: US
authors.lastname: Gaipl
authors.forename: A
authors.initials: A
authors.lastname: Sheriff
authors.forename: S
authors.initials: S
authors.lastname: Franz
authors.forename: L E
authors.initials: LE
authors.lastname: Munoz
authors.forename: R E
authors.initials: RE
authors.lastname: Voll
authors.forename: J R
authors.initials: JR
authors.lastname: Kalden
authors.forename: M
authors.initials: M
authors.lastname: Herrmann
mesh_terms: D000818:Animals; D017209:Apoptosis; D001327:Autoimmune Diseases / Q000209:etiology*; D015551:Autoimmunity; D002097:C-Reactive Protein / Q000502:physiology; D003165:Complement System Proteins / Q000502:physiology; D003850:Deoxyribonuclease I / Q000502:physiology; D006801:Humans; D008562:Membrane Glycoproteins / Q000502:physiology; D010718:Phosphatidylserines / Q000502:physiology; D000683:Serum Amyloid P-Component / Q000502:physiology
chemical_list: D008562:Membrane Glycoproteins; D010718:Phosphatidylserines; D000683:Serum Amyloid P-Component; D003165:Complement System Proteins; D002097:C-Reactive Protein; D003850:Deoxyribonuclease I